Antimicrobial susceptibility patterns of Streptococcus pneumoniae in Mexico

Diagnostic Microbiology and Infectious Disease

Volumn 49, Issue 1, 2004, Pages 53-58

  Quiñones Falconi, Francisco ^a   Calva, Juan José ^b   López Vidal, Yolanda ^c   Galicia Velazco, Miriam ^a   Jiménez Martinez, María Elena ^a   Larios Mondragón, Lina ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b Unidad de Epidemiologia Clinica   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; MEXICO; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CONFIDENCE INTERVALS; DRUG RESISTANCE, BACTERIAL; HUMANS; MEXICO; MICROBIAL SENSITIVITY TESTS; ODDS RATIO; PNEUMOCOCCAL INFECTIONS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; STREPTOCOCCUS PNEUMONIAE;

EID: 2342454318     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.02.001     Document Type: Article

References (30)

1. American Thoracic Society Official Statement (2001). Guidelines for the management of adults with community-acquired pneumonia, diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 163:1730-1754
2. Bartlett J.G., Dowell S.F., Mandell L.A., File T.M., Muscher D.M., Fine M.J. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 31:2000;347-382
3. Buckingham S.C., Brown S.P., Joaquin V.H. Breakthrough bacteremia and meningitis during treatment parenterally with cephalosporins for pneumococcal pneumonia. J Pediatr. 132:1998;174-176
4. Choi E., Lee H. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean Children. Clin Infect Dis. 6:1998;1346-1354
5. Deeks S.L., Palacio R., Ruvinsky R., Kertesz D.A., Hortal M., Rossi A., Spik J.S., DiFabio J.L. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. Pediatrics. 103:1999;409-413
6. Doern G.V., Heilmann K.P., Huynh H.K., Rhomberg P.R., Coffman S.L., Brueggemann A.B. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 45:2001;1721-1729
7. Dowell S.F., Butler J.C., Giebink G.S., Jacobs M.R., Jernigan D., Musher D.M., Rakowksy A., Shwarts B. The Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Acute otitis media. Management and surveillance in an era of pneumococcal resistance. A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 18:1999;1-9
8. Dowell S.F., Smith T., Leversedge K., Snitzer J. Pneumonia treatment failure associated with highly resistant pneumococci. Clin Infect Dis. 29:1999;462-463
9. Echaniz-Aviles G., Velazquez-Meza M.E., Carnalla-Barajas M.N., Soto-Nogueron A., Di Fabio J.L., Solorzano-Santos F., Jimenez-Tapia Y., Tomasz A. Predominance of the multiresistant 23F international clone of Streptococcus pneumoniae among isolates from Mexico. Microbiol Drug Resist. 4:1998;241-246
10. Feikin D., Schuchat A., Kolczak M., Barret N.L., Harrison L.H., Lefkowitz L., McGeer A., Farley M.M., Vugia D.J., Lexau C., Stefonek K.R., Patterson J.E., Jorgensen J.H. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health. 90:2000;223-229
11. Felmingham D, Washington J, The Alexander Project Group (1999). Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens. Findings of the Alexander Project 1992-1996. J Chemother 11:5-21
12. Friedland I.R. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J. 14:1995;885-890
13. Heffelfinger J.D., Dowell S.F., Jorgensen J.H., Klugman K.P., Mabry J.D., Musher D.M., Plouffe J.F., Rakowsky A., Schuchat A., Whitney C.G. The Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med. 160:2000;1399-1408
14. Ho P.L., Yung R.W.H., Tsang D.N.C., Que T.L., Ho M., Seto W.H., Ng T.K., Yam W.C., Ng W.W.S. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones Results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother. 48:2001;659-665
15. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN (2001). Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32:S81-S93
16. Jacobs MR (1999). Drug-resistant Streptococcus pneumoniae: Rational antibiotic choices. Am J Med 106:19S-25S
17. Jacobs M.R. In vivo veritas In vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure. Clin Infect Dis. 35:2002;565-569
18. Jacobs M.R., Appelbaum P.C. LASER Study Group. Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries. Int J Antimicrob Agents. 16:2000;17-24
19. Jacobs M.R., Bajaksouzian S., Zilles A., Lin G., Pankuch G.A., Appelbaum P.C. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters 1997 U.S. Surveillance Study. Antimicrob Agents Chemother. 43:2000;1901-1908
20. Jacobs MR, Weinberg W (2001). Evidence-based guidelines for treatment of bacterial respiratory tract infections in the era of antibiotic resistance. Managed Care Interface April, 68-80
21. Legg J.M., Bint A.J. Will pneumococci put quinolones in their place? J Antimicrob Chemother. 44:1999;425-427
22. Lonks J.R., Garau J., Gomez L., Xercavins M., Ochoa de Echaguen A., Gareen I.F., Reiss P.T., Medeiros A.A. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis. 35:2002;556-564
23. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th edition:2003;Approves standard M7-A6, Wayne, PA
24. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 2003;13th informational supplement M100-S13, Wayne, PA
25. Pallares R., Linares J., Vadillo M., Cabellow C., Manresa F., Viladrich P.F., Martin R., Gudiol F. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 333:1995;474-480
26. Perez-Trallero E., Garcia-Rey C., Martin-Sanchez A.M., Aguilar R., Garcia-de-Lomas J., Ruiz J. The Spanish Surveillance Group for Respiratory Pathogens (SAUCE Program). Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain. Antimicrob Agents Chemother. 46:2002;2665-2667
27. Pfaller M.A., Jones R.N. Gatifloxacin Phase IV Surveillance Trial (TeqCES Study) utilizing 5000 primary care physician practices Report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections. Diagn Microbiol Infect Dis. 44:2002;77-84
28. Ross J.J., Worthington M.G., Gorbach S.L. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med. 347:2002;65-66
29. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 123:2000;1-32
30. Turett G.S., Blum S., Fazal B.A., Justman J.E., Telzak E.E. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high HIV seroprevalence. Clin Infect Dis. 29:1999;321-327